Who is sponsoring NCT05556694?

NCT05556694 is sponsored by Damanhour University.

What drugs are being tested in NCT05556694?

Interventions in NCT05556694: calculation of cumulative fluid balance.

What condition does NCT05556694 study?

NCT05556694 studies Ventilator Associated Event.

Is NCT05556694 still recruiting?

NCT05556694 is currently completed. Last updated 15 August 2023.

Last reviewed 2023-08-15 · How we verify

NCT05556694

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cumulative Fluids Balance and Ventilator Associated Events

Completed Last updated 15 August 2023

What this trial tests

trial testing calculation of cumulative fluid balance in Ventilator Associated Event in 150 participants. Completed in 18 May 2023.

Timeline

18 October 2022

Primary endpoint
18 April 2023

18 May 2023

Quick facts

Lead sponsor	Damanhour University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	18 October 2022
Primary completion	18 April 2023
Estimated completion	18 May 2023
Sites	1 location across Egypt

Drugs / interventions tested

calculation of cumulative fluid balance

Conditions studied

Ventilator Associated Event — all drugs for Ventilator Associated Event →

Sponsor

Damanhour University

Who can join

Adults 18 to 75, any sex, with Ventilator Associated Event. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fluid therapy is widely used to improve organ perfusion and survival in critically patients. Fluid therapy is an important component of intensive care management; however, optimal fluid management is unknown. Inadequate or excessive fluid resuscitation, on the other hand, is linked with a poor prognosis; the former can cause tissue hypo-perfusion and exacerbate organ dysfunction, while the latter can raise the risk of heart failure, pulmonary edema, and pleural effusions. Ventilator-associated lung injury (VALI) is a devastating complication of assisted mechanical ventilation (MV) and is one of the root causes of prolonged MV.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Damanhour University trials

Trials by the same sponsor.

NCT07307911 — Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy · Phase 2 · completed
NCT07341893 — Sacubitril-valsartan in Patients With Heart Failure. · NA · recruiting
NCT07063628 — Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity · completed
NCT06849388 — Effect of HeartMath Intervention on Stress, Emotional Vitality and Sense of Coherence · NA · recruiting
NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05556694 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Damanhour University
Last refreshed: 15 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05556694.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing